127 results
Page 5 of 7
6-K
EX-99.1
hu0t pmyr80i57joi1qn
4 Aug 22
XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration
7:00am
6-K
EX-99.1
ut8inz
22 Jul 22
XORTX Reports Annual & Special Meeting Results
8:00am
6-K
EX-99.1
kgq2ik h30dhq
19 Jul 22
XORTX Announces Submission to European Medicines Agency
7:00am
6-K
EX-99.1
eeovdy1bpqiy0 44d
14 Jul 22
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial
11:03am
6-K
EX-99.1
6x7 zc4cvd
7 Jul 22
Current report (foreign)
7:00am
6-K
EX-99.1
0fnac
29 Jun 22
Current report (foreign)
9:58pm
6-K
EX-99.1
r0cguk7ccexj7b
21 Jun 22
XORTX Announces “Fireside Chat” with XORTX CEO
7:52pm
6-K
EX-99.1
0labrxiy
13 Jun 22
XORTX to Present at BIO International Convention 2022
9:26am
6-K
EX-99.1
dq4r98rwlk i1e
8 Jun 22
XORTX to Present at LD Micro Invitational 2022
7:00am
6-K
EX-99.1
4359gylsy imsph6m2p
6 Jun 22
XORTX Welcomes New Member to the Board of Directors and Appoints Chair
7:00am
6-K
EX-99.1
2g20p5 z9
25 May 22
XORTX to Present at H. C. Wainwright Global Investment Conference 2022
8:00am
6-K
EX-99.2
a2gzikw32
16 May 22
Condensed Interim Consolidated Financial Statements
7:25am
6-K
EX-99.1
o140 grmok5b3
5 May 22
Current report (foreign)
7:00am
20-F
sva 9tfidk
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.27
co5a6fj4p
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-15.1
mym8a72qtr8xan
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.20
gls1853g u9
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
2j4hnl955lff2fvnx
3 May 22
XORTX Initiates Dosing of Human Subjects in the XRX-OXY-101 Clinical Trial
7:03am
6-K
EX-99.1
vdbqkr
20 Apr 22
XORTX Receives Small and Medium Enterprise Status for the European Union
7:45am
6-K
EX-99.1
qlh7pc64jwh 5u
13 Apr 22
Current report (foreign)
7:23am